TABLE 1.
ZIKV-immune plasma samples included in this studya
Sample ID |
Subject age (yrs) |
Sex | Place of exposure |
Collection time (days)b |
Status | Diagnostic tests and results |
---|---|---|---|---|---|---|
Hu0002 | 28 | M | Miami, FL | Not applicable | Healthy | Negative for ZIKV, DENV1–DENV4, and CHIKV by PCR and ELISA |
Hu0007 | 53 | M | Colombia | 30 | Symptomatic | Positive for ZIKV by PCR and ELISA, negative for DENV1–DENV4 by ELISA |
Hu0015c | 32 | F | Miami (Wynwood), FL |
5, 7, 15, 21, 28, 48, 56, 70, 91, 116, 148, 249 |
Symptomatic | Positive for ZIKV, negative for DENV1–DENV4 by PCR and ELISA |
Hu0020 | 32 | F | Miami (Miami Beach), FL |
180 | Symptomatic | Positive for ZIKV by ELISA and PRNT, negative for DENV1–DENV4 by ELISA |
Hu0046 | 57 | F | Cuba | 7, 15, 24, 59 | Symptomatic | Positive for ZIKV by ELISA, negative for DENV1–DENV4 and CHIKV by PCR |
Hu0049 | 31 | F | Miami, FL | 247 | Asymptomatic | Positive for ZIKV by ELISA and PRNT, negative for DENV1–DENV4 by ELISA |
HuK021 | 36 | F | Miami, FL | 540 | Asymptomatic | Positive for ZIKV by ELISA and PRNT, negative for DENV1–DENV4 by ELISA |
HuK156 | 20 | Fd | Miami, FL | 90 | Asymptomatic | Positive for ZIKV by ELISA and PRNT, negative for DENV1–DENV4 by ELISA |
UTMB3 | 26 | F | Honduras | 8 | Symptomatic | Positive for ZIKV by ELISA |
UTMB4 | 26 | F | Caribbean Islands | 18 | Symptomatic | Positive for ZIKV by ELISA |
UTMB7 | 15 | F | Colombia | 129 | Symptomatic | Positive for ZIKV, negative for DENV1–DENV4 by PRNT |
UTMB8 | 28 | F | Colombia | 113 | Symptomatic | Positive for ZIKV, negative for DENV1–DENV4 by PRNT |
UTMB134 | 60 | F | Colombia | 23 | Symptomatic | Positive for ZIKV by PCR, negative for DENV1–DENV4 and CHIKV by PCR |
BSRI39 | 43 | F | Mexico | 28, 41, 91, 180, 285 |
Asymptomatic | Positive for ZIKV, negative for DENV1–DENV4 by PCR and ELISA |
BSRI40 | 26 | M | NA | 25, 38, 89, 180, 297 |
Symptomatic | Positive for ZIKV, negative for DENV1–DENV4 by PCR and ELISA |
BSRI45 | 28 | F | Puerto Rico | 16, 87 | Asymptomatic | Positive for ZIKV, negative for DENV1–DENV4 by PCR and ELISA |
ID, identifier; F, female; M, male; CHIKV, chikungunya virus; NA, not available.
Plasma collection times indicate number of days after the onset of symptoms for symptomatic individuals and post-index donation, the number of days after the first collection day, for asymptomatic individuals.
Plasma samples from this individual were previously studied for ZIKV-induced immunity (Ricciardi et al. [29]). Gray-shaded data represent samples derived from asymptomatic volunteers.
Individual was pregnant.